Galapagos NV GLPG:NASDAQ

RT Quote | NASDAQ | USD
Last | 09/28/22 EDT
42.89quote price arrow up+0.40 (+0.94%)
Volume
119,991
52 week range
42.15 - 72.11
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close42.89
  • 52 Week High72.11
  • 52 Week High Date04/07/22
  • 52 Week Low42.15
  • 52 Week Low Date09/26/22

Key Stats

  • Market Cap2,862.48M
  • Shares Out65.73M
  • 10 Day Average Volume0.15M
  • Dividend-
  • Dividend Yield-
  • Beta0.01
  • YTD % Change-22.2

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close42.89
  • 52 Week High72.11
  • 52 Week High Date04/07/22
  • 52 Week Low42.15
  • 52 Week Low Date09/26/22
  • Market Cap2,862.48M
  • Shares Out65.73M
  • 10 Day Average Volume0.15M
  • Dividend-
  • Dividend Yield-
  • Beta0.01
  • YTD % Change-22.2

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date11/03/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Galapagos NV

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Galapagos NV is a Belgium-based clinical-stage biotechnology company. The Company is engaged in the discovery and development of small molecule medicines with novel modes of action. Its pipeline comprises Phase 3, 2, 1, pre-clinical studies and discovery small-molecule and antibody programs in cystic fibrosis, inflammation, and other indications. The Company focuses on developing a portfolio of clinical-stage therapies for the enhancement of existing treatment paradigms. It...
Paulus Stoffels
Chairman of the Board, Chief Executive Officer
Bart Filius
President, Chief Financial Officer, Chief Operating Officer, Member of the Management Board
Address
Generaal De Wittelaan 3
Malines (mechelen)
2800
Belgium

Top Peers

SYMBOLLASTCHG%CHG
ACAD
ACADIA Pharmaceuticals Inc
16.79+0.06+0.36%
ABCL
Abcellera Biologics Inc
9.97+0.54+5.73%
RARE
Ultragenyx Pharmaceutical Inc
41.27+0.98+2.43%
FOLD
Amicus Therapeutics Inc
10.69+0.45+4.39%
PTCT
PTC Therapeutics Inc
51.18+1.78+3.60%